The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients
Open accessAbstract
Purpose: While studies have found that adjuvant hormonal therapy for hormone-sensitive breast cancer (BC) dramatically reduces recurrence and mortality, adherence to medications is suboptimal. We investigated the rates and predictors of early discontinuation and nonadherence to hormonal therapy in patients enrolled in Kaiser Permanente of Northern California health system. Patients and Methods: We identified women diagnosed with hormone-sensitive stage I-III BC from 1996 to 2007 and used automated pharmacy records to identify hormonal therapy prescriptions and dates of refill. We used Cox proportional hazards regression models to analyze factors associated with early discontinuation and nonadherence (medication possession ratio < 80%) of hormonal therapy. Results: We identified 8,769 patients with BC who met our eligibility criteria and who filled at least one prescription for tamoxifen (43%), aromatase inhibitors (26%), or both (30%) within 1 year of diagnosis. Younger or older age, lumpectomy (v mastectomy), and comorbidities were associated with earlier discontinuation, while Asian race, being married, earlier year at diagnosis, receipt of chemotherapy or radiotherapy, and longer prescription refill interval were associated with completion of 4.5 years of therapy. Of those who continued therapy, similar factors were associated with full adherence. Women age younger than 40 years had the highest risk of discontinuation (hazard ratio, 1.51; 95% CI, 1.23 to 1.85). By 4.5 years, 32% discontinued therapy, and of those who continued, 72% were fully adherent. Conclusion: Only 49% of patients with BC took adjuvant hormonal therapy for the full duration at the optimal schedule. Younger women are at high risk of nonadherence. Interventions to improve adherence and continuation of hormonal therapy are needed, especially for younger women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Development of a comorbidity index using physician claims data
Klabunde, C. N., Potosky, A. L., Legler, J. M., & Warren, J. L. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00256-0 · Cited by 1,845
Krieger, N. (1992) · American Journal of Public Health · doi:10.2105/ajph.82.5.703 · Cited by 1,654
Influence of delay on survival in patients with breast cancer: a systematic review
Richards, M., Westcombe, A., Love, S., Littlejohns, P., & Ramirez, A. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02143-1 · Cited by 1,171
Methods for evaluation of medication adherence and persistence using automated databases
Andrade, S. E., Kahler, K. H., Frech, F., & Chan, K. A. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1230 · Cited by 1,079
Winer, E. P., Hudis, C., Burstein, H. J., Wolff, A. C., Pritchard, K. I., Ingle, J. N., Chlebowski, R. T., Gelber, R., Edge, S. B., Gralow, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.121 · Cited by 1,031
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
Partridge, A. H., Wang, P. S., Winer, E. P., & Avorn, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.071 · Cited by 676
Adherence to Therapy With Oral Antineoplastic Agents
Partridge, A. H. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.9.652 · Cited by 584
Pharmacy Benefits and the Use of Drugs by the Chronically Ill
Goldman, D. P. (2004) · JAMA · doi:10.1001/jama.291.19.2344 · Cited by 530
Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer
Partridge, A. H., LaFountain, A., Mayer, E., Taylor, B. S., Winer, E., & Asnis-Alibozek, A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.5451 · Cited by 482
McCowan, C., Shearer, J., Donnan, P. T., Dewar, J. A., Crilly, M., Thompson, A. M., & Fahey, T. P. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604758 · Cited by 343
Young Adult Oncology: The Patients and Their Survival Challenges
Bleyer, A. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.4.242 · Cited by 324
Adherence to tamoxifen over the five-year course
Lash, T. L., Fox, M. P., Westrup, J. L., Fink, A. K., & Silliman, R. A. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9193-0 · Cited by 320
Racial Disparities in Treatment and Survival Among Women With Early-Stage Breast Cancer
Hershman, D., McBride, R., Jacobson, J. S., Lamerato, L., Roberts, K., Grann, V. R., & Neugut, A. I. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.633 · Cited by 308
Self-citationOwusu, C., Buist, D. S. M., Field, T. S., Lash, T. L., Thwin, S. S., Geiger, A. M., Quinn, V. P., Frost, F., Prout, M., Yood, M. U., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.1022 · Cited by 304
Adjuvant Tamoxifen: Predictors of Use, Side Effects, and Discontinuation in Older Women
Demissie, S., Silliman, R. A., & Lash, T. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.322 · Cited by 300
Fink, A. K., Gurwitz, J., Rakowski, W., Guadagnoli, E., & Silliman, R. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.064 · Cited by 281
Early discontinuation of tamoxifen: A Lesson for oncologists
Barron, T. I., Connolly, R., Bennett, K., Feely, J., & Kennedy, M. J. (2007) · Cancer · doi:10.1002/cncr.22485 · Cited by 279
Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer
Ziller, V., Kalder, M., Albert, U.-S., Holzhauer, W., Ziller, M., Wagner, U., & Hadji, P. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn646 · Cited by 263
Swedish Breast Cancer Cooperative Group (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.21.1543 · Cited by 261
Adherence to endocrine therapy for breast cancer
Chlebowski, R. T., & Geller, M. L. (2006) · Oncology · doi:10.1159/000100444 · Cited by 251
Assessing the health care needs of adolescent and young adult cancer patients and survivors
Zebrack, B., Bleyer, A., Albritton, K., Medearis, S., & Tang, J. (2006) · Cancer · doi:10.1002/cncr.22338 · Cited by 251
Adherence beliefs among breast cancer patients taking tamoxifen
Grunfeld, E. A., Hunter, M. S., Sikka, P., & Mittal, S. (2005) · Patient Education and Counseling · doi:10.1016/j.pec.2004.10.005 · Cited by 245
Elkin, E. B., Hurria, A., Mitra, N., Schrag, D., & Panageas, K. S. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6053 · Cited by 224
Adjuvant hormonal therapy use among insured, low-income women with breast cancer
Kimmick, G., Anderson, R., Camacho, F., Bhosle, M., Hwang, W., & Balkrishnan, R. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.2419 · Cited by 198
Silliman, R. A., Guadagnoli, E., Weitberg, A. B., & Mor, V. (1989) · Journal of Gerontology · doi:10.1093/geronj/44.2.m46 · Cited by 191
Validity of a Prescription Claims Database to Estimate Medication Adherence in Older Persons
Grymonpre, R., Cheang, M., Fraser, M., Metge, C., & Sitar, D. S. (2006) · Medical Care · doi:10.1097/01.mlr.0000207817.32496.cb · Cited by 187
Du, X. L., Fang, S., Vernon, S. W., El‐Serag, H., Shih, Y. T., Davila, J., & Rasmus, M. L. (2007) · Cancer · doi:10.1002/cncr.22826 · Cited by 180
Duration of Adjuvant Chemotherapy for Colon Cancer and Survival Among the Elderly
Neugut, A. I., Matasar, M., Wang, X., McBride, R., Jacobson, J. S., Tsai, W.-Y., Grann, V. R., & Hershman, D. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5005 · Cited by 170
Self-citationDelay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women
Hershman, D. L., Wang, X., McBride, R. B., Jacobson, J. S., Grann, V. R., & Neugut, A. I. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9206-z · Cited by 157
Self-citationMortality Impact of Less-than-Standard Therapy in Older Breast Cancer Patients
Yood, M. U., Owusu, C., Buist, D. S. M., Geiger, A. M., Field, T. S., Thwin, S. S., Lash, T. L., Prout, M. N., Wei, F., Quinn, V. P., et al. (2008) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.07.015 · Cited by 155
Machin, D., & Andersen, K. W. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.9.659 · Cited by 155
Completion of therapy by Medicare patients with stage III colon cancer
Dobie, S. A., Baldwin, L.-M., Dominitz, J. A., Matthews, B., Billingsley, K., & Barlow, W. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj159 · Cited by 150
Cancer in Young Adults 20 to 39 Years of Age: Overview
Bleyer, A., & Barr, R. (2009) · Seminars in Oncology · doi:10.1053/j.seminoncol.2009.03.003 · Cited by 144
Adjuvant Therapy for Breast Cancer: Practice Patterns of Community Physicians
Harlan, L. C., Abrams, J. S., Warren, J. L., Clegg, L., Stevens, J. L., & Ballard-Barbash, R. R. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.052 · Cited by 119
Magai, C., Consedine, N. S., Neugut, A. I., & Hershman, D. L. (2007) · Journal of Women s Health · doi:10.1089/jwh.2006.0024 · Cited by 115
Self-citationAdjuvant Tamoxifen Prescription in Women 65 Years and Older With Primary Breast Cancer
Silliman, R. A., Guadagnoli, E., Rakowski, W., Landrum, M. B., Lash, T. L., Wolf, R., Fink, A. K., Ganz, P. A., Gurwitz, J. H., Borbas, C., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.137 · Cited by 92
Morris, M. J., Platell, C. F. E., Fritschi, L., & Iacopetta, B. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603627 · Cited by 87
Recurrences and second primary breast cancers in older women with initial early‐stage disease
Geiger, A. M., Thwin, S. S., Lash, T. L., Buist, D. S. M., Prout, M. N., Wei, F., Field, T. S., Yood, M. U., Frost, F. J., Enger, S. M., et al. (2007) · Cancer · doi:10.1002/cncr.22472 · Cited by 77
Locker, G. Y., Mansel, R. E., Cella, D. F., Dobrez, D. G., Sorensen, S. V., Gandhi, S., & on behalf of the ATAC Trialists’ Group (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9483-6 · Cited by 74
Differences in treatment patterns for localized breast carcinoma among Asian/Pacific islander women
Prehn, A. W., Topol, B., STEWART, S. L., Glaser, S. L., O’Connor, L., & West, D. W. (2002) · Cancer · doi:10.1002/cncr.10965 · Cited by 68
Duration of Adjuvant Tamoxifen Therapy
Bryant, J., Fisher, B., & Dignam, J. J. (2001) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003462 · Cited by 61
Magai, C., Consedine, N. S., Adjei, B. A., Hershman, D. L., & Neugut, A. I. (2006) · Health Education & Behavior · doi:10.1177/1090198107303281 · Cited by 46
Self-citationHawley, S. T., Ricketts, T. C., Paskett, E. D., Hatzell, T. A., Cooper, M. R., & Aldrich, T. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006279117650 · Cited by 41
The effect of prescription size on acquisition of maintenance medications
Steiner, J. F., Robbins, L. J., Roth, S., & Hammond, W. S. (1993) · Journal of General Internal Medicine · doi:10.1007/bf02600143 · Cited by 38
Do people with cancer comply with oral chemotherapy treatments?
Escalada‐Hernández, P., & Griffiths, P. (2006) · British Journal of Community Nursing · doi:10.12968/bjcn.2006.11.12.22424 · Cited by 38
Gomez, S. L., France, A.-M., & Lee, M. M. (2004) · PubMed · Cited by 32
Chia, Y. H., & Ma, C. (2009) · Breast Diseases A Year Book Quarterly · doi:10.1016/s1043-321x(09)79377-4 · Cited by 28
Cited by
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
Pan, H., Gray, R., Braybrooke, J., Davies, C., Taylor, C., McGale, P., Peto, R., Pritchard, K. I., Bergh, J., Dowsett, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701830 · Cited by 1,822
Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens-Alvarado, R. L., Cannady, R. S., Pratt-Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.3809 · Cited by 1,071
Hershman, D. L., Shao, T., Kushi, L. H., Buono, D., Tsai, W. Y., Fehrenbacher, L., Kwan, M., Gomez, S. L., & Neugut, A. I. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1132-4 · Cited by 870
Self-citationHoward-Anderson, J., Ganz, P. A., Bower, J. E., & Stanton, A. L. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr541 · Cited by 830
Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens‐Alvarado, R. L., Cannady, R. S., Pratt‐Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21319 · Cited by 728
Metadata
- Authors
- Hershman, D. L., Kushi, L. H., Shao, T., Buono, D., Kershenbaum, A., Tsai, W.-Y., Fehrenbacher, L., Lin Gomez, S., Miles, S., & Neugut, A. I.
- Venue
- Journal of Clinical Oncology
- Published
- 2010-09-20
- Volume
- 28
- Issue
- 27
- Pages
- 4120-4128
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2134839096
- Cited by
- 828
- References
- 50
- FWCI
- 44.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.